Icon Advisers Inc Jazz Pharmaceuticals PLC Transaction History

Icon Advisers Inc

$451 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$122.5 - $147.16 $1.3 Million - $1.56 Million	-10,600 Reduced 59.55%	7,200 $892,000
Q1 2023 May 12, 2023	BUY	$133.98 - $160.47 $790,481 - $946,773	5,900 Added 49.58%	17,800 $2.6 Million
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $1.54 Million - $1.9 Million	11,900 New	11,900 $1.9 Million
Q4 2020 Feb 02, 2021	SELL	$140.71 - $165.05 $1.01 Million - $1.19 Million	-7,202 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$105.46 - $144.13 $976,770 - $1.33 Million	-9,262 Reduced 56.26%	7,202 $1.03 Million
Q2 2020 Aug 03, 2020	SELL	$95.68 - $121.88 $1.35 Million - $1.72 Million	-14,120 Reduced 46.17%	16,464 $1.82 Million
Q3 2019 Nov 01, 2019	SELL	$125.18 - $143.24 $287,914 - $329,452	-2,300 Reduced 6.99%	30,584 $3.92 Million
Q2 2019 Aug 02, 2019	SELL	$125.55 - $144.48 $9.81 Million - $11.3 Million	-78,110 Reduced 70.37%	32,884 $4.69 Million
Q1 2019 May 01, 2019	SELL	$121.81 - $142.95 $341,068 - $400,259	-2,800 Reduced 2.46%	110,994 $15.9 Million
Q4 2018 Feb 04, 2019	BUY	$115.94 - $166.74 $14,840 - $21,342	128 Added 0.11%	113,794 $14.1 Million
Q3 2018 Nov 05, 2018	SELL	$161.01 - $180.57 $1.51 Million - $1.69 Million	-9,353 Reduced 7.6%	113,666 $19.1 Million
Q2 2018 Aug 03, 2018	BUY	$146.33 - $183.18 $2.16 Million - $2.7 Million	14,762 Added 13.64%	123,019 $21.2 Million
Q1 2018 Apr 30, 2018	SELL	$135.59 - $157.16 $216,944 - $251,456	-1,600 Reduced 1.46%	108,257 $16.3 Million
Q4 2017 Feb 06, 2018	BUY	$131.06 - $150.39 $96,591 - $110,837	737 Added 0.68%	109,857 $14.8 Million
Q3 2017 Nov 08, 2017	BUY	$142.62 - $155.6 $15.6 Million - $17 Million	109,120	109,120 $16 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Icon Advisers Inc with notifications on news.

Account